<div class="white-sheet">
	<div class="content-slide">

		<div class="title-bar red"></div>

		<div class="wrapper slide-2-1-1-1">

			<div class="popups" style="position:absolute">
				<div data-effect="fade" data-duration="1000" data-target="references-overlay" data-width="600" data-height="490" class="references-button show-overlay"></div>			
				<div data-effect="fade" data-duration="1000" data-target="information-overlay" data-width="600" data-height="490"  class="information-button show-overlay"></div>	
			</div>

			<div class="slide-title red">
				Aplastic anaemia is a consequence of bone marrow failure 
			</div>


			<div class="content-container">

					<ul>
						<li><span>Aplastic anaemia is a rare but heterogeneous disorder,1 first described by Paul Ehrlich in 1888<sup>2</sup></span>
							<ul>
								<li><span>It is characterised by bone marrow failure<sup>1</sup></span>
									<ul>
										<li><span>Aplastic anaemia may also be referred to as a bone marrow failure syndrome<sup>3</sup></span></li>
									</ul>
								</li>
								<li><span>It affects both genders<sup>1</sup></span></li>
							</ul>
						</li>
						<li><span>Although aplastic anaemia may occur in all age groups, there is a biphasic age distribution, with peaks in two age groups:<sup>1</sup></span>
							<ul>
								<li><span>Between 10 and 25 years of age</span></li>
								<li><span>In individuals older than 60 years</span></li>
							</ul>
						</li>
						<li><span>Aplastic anaemia is associated with premature mortality<sup>3</sup></span></li>
						<li><span>In ~10–15% of cases, the precipitating factor is known<sup>3</sup></span>
							<ul>
								<li><span>For example, chemotherapy or infections (including hepatitis viruses)</span></li>
							</ul>
						</li>
						<li><span>In ~70% of cases, aplastic anaemia is idiopathic<sup>3</sup></span></li>
					</ul>

			</div>

		</div>

		<div class="information-overlay overlay">
			
			<header>Aplastic anaemia is a consequence of bone marrow failure</header>

			<ul>
				<li><span>Aplastic anaemia/bone marrow failure syndromes refers to the inability of the bone marrow to produce healthy levels of blood cells<sup>3</sup></span></li>
				<li><span>The condition is characterised by:<sup>4</sup></span>
					<ul>
						<li><span>Pancytopenia (a reduced number of all blood cell types, e.g. red blood cells, neutrophils and platelets)<sup>4</sup></span></li>
						<li><span>Hypocellular bone marrow in the absence of abnormal infiltration or increased reticulin<sup>4</sup></span></li>
					</ul>
				</li>
				<li><span>Aplastic anaemia can be either inherited or acquired<sup>4</sup></span></li>
			</ul>

		</div>


		<div class="references-overlay overlay">

			<header>References</header>
				
			<ul>
				<li class="navigateHref" data-navtarget="media/documents/BolonB-2012-ToxicolPathol-v40p216.pdf"><span>Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43</span></li>
				<li class="navigateHref" data-navtarget="media/documents/BolonB-2012-ToxicolPathol-v40p216.pdf"><span>Young NS & Maciejewski J. <i>N Eng J Med</i> 1997;336:1365 </span></li>
				<li class="navigateHref" data-navtarget="media/documents/BolonB-2012-ToxicolPathol-v40p216.pdf"><span>Dokal I & Vulliamy T. <i>Blood Reviews</i> 2008; 22:141</span></li>
				<li class="navigateHref" data-navtarget="media/documents/BolonB-2012-ToxicolPathol-v40p216.pdf"><span>DeZern AE & Brodsky RA. <i>Exp Rev Hematol</i> 2011;4:221</span></li>
			</ul>

		</div>

	</div>
</div>